Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 3/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.33 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.33 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15298698 | 0.81 | DCLK1 (0.39) | MAPTALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL23145180 | 0.79 | L3MBTL1 (0.54) | MAPTKDM4EHIF1ALMNAALDH1A1 | |
| SCHEMBL15298674 | 0.78 | JAK2 (0.34) | MAPTKDM4EHSD17B10HIF1AMEN1 | |
| SCHEMBL15298671 | 0.78 | JAK2 (0.34) | MAPTKDM4EHSD17B10HIF1AMEN1 | |
| SCHEMBL9921575 | 0.77 | KIF11 (0.45) | HSD17B10ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL13387379 | 0.76 | MAPT (0.35) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| SCHEMBL12587613 | 0.76 | L3MBTL1 (0.39) | MAPTKDM4EHSD17B10HIF1AALDH1A1 | |
| SCHEMBL15298664 | 0.75 | JAK2 (0.39) | MEN1KMT2A | |
| SCHEMBL15298669 | 0.75 | JAK2 (0.39) | MEN1KMT2A | |
| SCHEMBL14701343 | 0.75 | ESR1 (0.36) | MAPTKDM4EHSD17B10HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220389310-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2022-12-08 | — | — | US | claimed |
| WO-2021062035-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2021-04-01 | — | — | WO | claimed |
| US-20220389310-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2022-12-08 | — | — | US | disclosed |
| WO-2021062035-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2021-04-01 | — | — | WO | disclosed |
| US-20130256647-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CANON KABUSHIKI KAISHA (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130256647-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CANON KABUSHIKI KAISHA (JP) | 2013-10-03 | — | — | US | disclosed |
| WO-2012077478-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CANON KABUSHIKI KAISHA (JP) | 2012-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389310-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | TYR, GSTA2, CYBA | MAPT 2034/4885KDM4E 3167/4885HSD17B10 3261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.